Literature DB >> 560377

Ribonuclease inhibitor from human placenta. Purification and properties.

P Blackburn, G Wilson, S Moore.   

Abstract

A soluble ribonuclease inhibitor from the human placenta has been purified 4000-fold by a combination of ion exchange and affinity chromatography. The inhibitor has been isolated in 45% yield (about 2 mg/placenta) as a protein that is homogeneous by sodium dodecyl sulfate-gel electrophoresis. In common with the inhibitors of pancreatic ribonuclease from other tissues that have been studied earlier, the placental inhibitor is an acidic protein of molecular weight near 50,000; it forms a 1:1 complex with bovine pancreatic RNase A and is a noncompetitive inhibitor of the pancreatic enzyme, with a Ki of 3 X 10(-10) M. The amino acid composition of the protein has been determined. The protein contains 30 half-cystine plus cysteine residues determined as cysteic acid after performic acid oxidation. At pH 8.6 the nondenatured protein alkylated with iodoacetic acid in the presence of free thiol has 8 free sulfhydryl groups. The inhibitor is irreversibly inactivated by sulfhydryl reagents and also by removal of free thiol from solutions of the protein. Inactivation by sulfhydryl reagents causes the dissociation of the RNase - inhibitor complex into active RNase and inactive inhibitor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 560377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Tuning the pK(a) of fluorescein to optimize binding assays.

Authors:  Luke D Lavis; Thomas J Rutkoski; Ronald T Raines
Journal:  Anal Chem       Date:  2007-08-03       Impact factor: 6.986

Review 3.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

4.  Analysis of herpes simplex virus-induced mRNA destabilizing activity using an in vitro mRNA decay system.

Authors:  C M Sorenson; P A Hart; J Ross
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

5.  Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain.

Authors:  M P Sasso; A Carsana; E Confalone; C Cosi; S Sorrentino; M Viola; M Palmieri; E Russo; A Furia
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

6.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

7.  Ribonuclease activities in rat sympathetic ganglia: evidence for the presence of an endogenous inhibitor of alkaline ribonuclease.

Authors:  D J Bates; R T Good; L Austin
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

8.  Affinity chromatography of RNase inhibitor.

Authors:  M A Garcia; R J Klebe
Journal:  Mol Biol Rep       Date:  1997-11       Impact factor: 2.316

9.  The activity on double-stranded RNA of aggregates of ribonuclease A higher than dimers increases as a function of the size of the aggregates.

Authors:  M Libonati; M Bertoldi; S Sorrentino
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

10.  Role of mammalian RNase inhibitor in cell-free protein synthesis.

Authors:  G Scheele; P Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.